Denali Therapeutics Inc (DNLI) stock news · $2.11B cap
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
This DNLI news page leads with what Denali Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for DNLI yet. We will not pad this page with generic market recap.
Latest reported DNLI revenue for 2025-12-31 was $0. Net income was -$512.5M. DNLI currently screens at market cap $2.11B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the DNLI stock page; for the tape open the quote page.
DNLI stock news FAQ
What is DNLI's latest net income?
Latest cached Denali Therapeutics Inc (DNLI) net income was -$512.5M. Statements: https://lician.com/financials/dnli
What is DNLI's market cap?
Denali Therapeutics Inc (DNLI) market cap is $2.11B on the latest cached fundamentals snapshot.
What kind of company is DNLI?
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Where is DNLI stock news listed?
Cached stock news for Denali Therapeutics Inc (DNLI) is listed at https://lician.com/news/dnli. Filings: https://lician.com/sec/dnli
Not investment advice.